NCT03964636View on ClinicalTrials.gov

Contraceptive Pills and Retinal Vascularization

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 17, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2022

Conditions

Combined Oral Contraceptives Intake

Interventions

DIAGNOSTIC_TEST

OCT-A (optical coherence tomography)

Included patients will have an OCT-A and will be questioned about their medical and ophthalmologic history, and their oestro-progestative contraceptive intake.

Trial Locations (1)

75019

Fondation A de Rothschild, Paris

All Listed Sponsors

lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03964636 - Contraceptive Pills and Retinal Vascularization | Biotech Hunter | Biotech Hunter